ALAD anticorps (C-Term)
Aperçu rapide pour ALAD anticorps (C-Term) (ABIN452730)
Antigène
Voir toutes ALAD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects ALAD at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human ALAD
-
-
-
-
Indications d'application
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.121 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Autre désignation
- ALAD
-
Sujet
- The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 Molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria.Synonyms: ALADH, Delta-aminolevulinic acid dehydratase, Porphobilinogen synthase
-
Poids moléculaire
- 36295 Da
-
ID gène
- 210
-
NCBI Accession
- NP_000022
-
UniProt
- P13716
Antigène
-